The Formedix Clinic

Drop in and catch up on the latest news and standards knowledge. No appointment necessary.

Jasmine Kestemont

Jasmine Kestemont, Managing Partner at Innovion, is highly motivated to support organizations through change, whether it is in defining a new vision and strategy, process re-engineering, system implementation, outsourcing or reorganizations.

Jasmine deeply believes that any transition can only be successful if employees understand and buy in to a need for change.

After obtaining her master’s degrees in bioengineering and in medical and pharmaceutical research, she started working at a global CRO. She moved to pharma in 2003, where she implemented CDISC standards and led the first SDTM submission in 2005.

At Janssen, Jasmine was the driving force behind the implementation of a new data management process model providing a global end-to-end approach for the delivery of quality data on time and within budget. It also enabled implementation of a future-proof and deliverable-based outsourcing model.

From 2014 onwards she was responsible for all global data management activities across North America, Europe, and China.

In 2015 she took on the additional responsibilities of heading the global data management, statistical programming, risk management and central monitoring and regulatory medical writing teams and supporting capabilities in outsourcing, 3rd party vendor management, submission and archiving.

While thoroughly enjoying her career, Jasmine has decided to return to her original passion, optimizing processes, finding suitable technology to support implementation, finding efficiencies through standardization and supporting the development of young talent.

Find me on:

Recent Posts

Cost-benefit Analysis for the Implementation of CDISC Standards During Clinical Trial Setup – Calculating the Break-even Point - Part 2

24 May 2018
by Jasmine Kestemont About The Author

In the second article of this two-part series, Jasmine Kestemont from Innovion delves deeper into the cost-benefit analysis, focusing on the upfront investment required to implement CDISC standards at study setup and the break-even points for three different levels of standardization.

Read More

Cost-benefit Analysis for the Implementation of CDISC Standards During Clinical Trial Setup – Part 1

18 May 2018
by Jasmine Kestemont About The Author

In a two-part series, guest blogger Jasmine Kestemont, Managing Partner at Innovion, shares her findings from a cost-benefit analysis for CDISC data standards implementation during clinical trial setup. In this article, Kestemont reviews study setup activities from protocol to Define.xml creation, highlighting that any level of standardization has a direct and immediate impact on the effort required for trial setup. 

Read More